FDA.reportPublic FDA data

coagulation factor XIII a-subunit (recombinant) 1 UNT Injection

RxCUI
1488302
RxNorm name
coagulation factor XIII a-subunit (recombinant) 1 UNT Injection
Display name
coagulation factor XIII a-subunit (recombinant) 1 UNT Injection
Full name
coagulation factor XIII a-subunit (recombinant) 1 UNT Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125398TrettenCoagulation Factor XIII A-Subunit (Recombinant)351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8664978e-1814-4930-aca5-97a24455f6dfcoagulation factor XIII a-subunit (recombinant) 1 UNT InjectionPSN8These highlights do not include all the information needed to use TRETTEN safely and effectively. See full prescribing information for TRETTEN. TRETTEN, Coagulation Factor XIII A-Subunit (Recombinant) For Intravenous Use. Lyophilized Powder for Solution for Injection Initial U.S. Approval: 201320200630
8664978e-1814-4930-aca5-97a24455f6dfcoagulation factor XIII a-subunit (recombinant) 1 UNT InjectionSCD8These highlights do not include all the information needed to use TRETTEN safely and effectively. See full prescribing information for TRETTEN. TRETTEN, Coagulation Factor XIII A-Subunit (Recombinant) For Intravenous Use. Lyophilized Powder for Solution for Injection Initial U.S. Approval: 201320200630